Blog

Fiona Thistlethwaite – Pushing the Boundaries of Cancer Research and Personalised Medicine – MCRC

Fiona Thistlethwaite/research.manchester.ac.uk

May 28, 2025, 11:51

Fiona Thistlethwaite – Pushing the Boundaries of Cancer Research and Personalised Medicine – MCRC

Manchester Cancer Research Centre shared a post on LinkedIn:

“Alumni Spotlight: Professor Fiona Thistlethwaite.

After finishing her MB-PhD programme at The University of Cambridge in 1999, Fiona completed various training posts at the Royal Liverpool University Hospital, The Royal Marsden NHS Foundation Trust and The Christie NHS Foundation Trust.

She was appointed a Consultant at The Christie in 2007. Her academic focus is on developing early-phase clinical trials in immunotherapy and adoptive T-cell therapy — pushing the boundaries of cancer research and personalised medicine.

We spoke to Fiona to learn more about her career journey, research, and advice to prospective MB-PhD students. Read Fiona’s story.”

Manchester Cancer Research Centre profiled Professor Fiona Thistlethwaite, highlighting her career in immunotherapy and early-phase clinical trials, and her contributions to advancing personalised cancer treatment.

More posts featuring Manchester Cancer Research Centre.

cancer Cancer research clinical trials fight against cancer Fiona Thistlethwaite Global fight against cancer immunotherapy Manchester Cancer Research Centre medicine OncoDaily Oncology Royal Liverpool University Hospital T-cell therapy The Christie The Christie NHS Foundation Trust The Royal Marsden NHS Foundation Trust The University of Cambridge

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action